On September 17, METIS TECHBIO-P rose 5.08% in regular trading, trading at 14.48 HKD/share, with turnover of approximately 23.77 million HKD. The stock staged a technical rebound after consecutive sessions of heavy profit-taking that followed its inclusion in the Stock Connect program.

METIS TECHBIO-P was officially added to the Stock Connect eligible securities list on September 7, unlocking southbound capital access for mainland investors. The stock subsequently surged over 40% in the short term, but aggressive profit-taking emerged from September 10 onward, leading to multiple days of sharp declines. On September 16, the stock plunged 7.65% in a single session to close at 14.00 HKD. After sustained deep retracement, near-term selling pressure has been largely absorbed, paving the way for today's rebound.

On the fundamental side, the company reported first-half revenue of 154 million RMB, representing a year-over-year increase of over 133 times, while adjusted net losses narrowed by 56.4%. Its proprietary AiTEM AI formulation platform has been commercially deployed at Hengrui Medicine, and the NanoForge platform commercialization continues to advance. Market participants, however, remain mindful of an upcoming cornerstone investor lock-up expiry window in mid-November, which may weigh on sentiment.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)